InsidersTradesSigma
Follow the 誉衡药业 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 誉衡药业 has recorded 2 reports. Market capitalisation: €6.4bn. The latest transaction was reported on 1 July 2025 (Sale). Among the most active insiders: 李润宝. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
誉衡药业 es una empresa centrada en el sector de la salud y farmacéutico, especializada en el desarrollo y la fabricación de medicamentos. Cotiza en el mercado XSHE.